If CYDY main goal was to get Just EUA we would have had it 3 months ago with data we had at that time, company chose to go for the grand slam instead of the give me EUA... why? Because full approval would open the door for open label use and to use for all covid patients whether mild moderate sever or critical with many stipulations. Full approval would allow anyone in need to get the drug if supplies were available. Worst case scenario at this juncture would be not hitting Pvalue and only getting EUA. People will be hearing about and using leronlimab very very soon either way!